Skip to main content
HTGCHercules Capital, Inc.Hold6.0·$15.65+1.03%
Open full analysis

Hercules Capital, Inc. (HTGC) Stock Analysis

Recovery setup

HoldModerate Confidence

Financial Services · Asset Management

Hold if already holding. Not a fresh buy at $15.65, but acceptable to hold if already in. Reasons: Thin upside margin: 7.6%; Leverage penalty (D/E 1.1): -0.5.

Hercules Capital is an internally managed BDC regulated under the Investment Company Act of 1940 that provides senior secured loans and Structured Debt to venture capital-backed and institutional-backed companies in technology and life sciences sectors. The company has... Read more

$15.65+7.6% A.UpsideScore 6.0/10#32 of 112 Asset Management
QualityF-score4 / 9FCF yield8.55%
IncomeYield12.14%(5y avg 9.96%)Payout105.03%at-risk
Stop $15.07Target $16.84(analyst − 13%)A.R:R 1.5:1
Analyst target$19.36+23.7%9 analysts
$16.84our TP
$15.65price
$19.36mean
$25

Hold if already holding. Not a fresh buy at $15.65, but acceptable to hold if already in. Reasons: Thin upside margin: 7.6%; Leverage penalty (D/E 1.1): -0.5. Chart setup: Death cross but MACD improving, RSI 53. Mixed signals. Hold existing position. Score 6.0/10, moderate confidence.

Passes 6/9 gates (favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 44d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.

10-K grounded · weekly refresh

About Hercules Capital, Inc.

About Hercules Capital, Inc.

Hercules Capital has originated over $25.0 billion in commitments since inception through December 31, 2025, investing in venture capital-backed and institutional-backed technology and life sciences companies as a BDC regulated under the Investment Company Act of 1940. Portfolio fair value at year-end was approximately 87.1% concentrated in five industries, led by Application Software (24.3%) and Drug Discovery & Development (23.3%). The company held warrant and equity securities in 164 portfolio companies, with 97.9% of loans priced at floating rates of approximately 7% to 14%.

Hercules earns investment income primarily from interest and fees on Structured Debt—senior secured term loans with embedded warrants, equity options, or conversion rights—carrying maturities of 36 to 48 months. As an internally managed BDC, the company incurs operating costs directly rather than paying an external adviser, avoiding the management fee structure of externally managed peers. Income is supplemented by exit fees, balloon payment fees, commitment fees, and prepayment fees, while warrant and equity co-investments provide upside exposure at portfolio company liquidity events. The 1940 Act requires a minimum 150% asset-coverage ratio on borrowings, constraining available debt financing. An Adviser Subsidiary—separately registered as a registered investment adviser—manages third-party funds for external investors, generating supplemental advisory fee income. The company focuses on companies backed by established venture capital and private equity sponsors; as of December 31, 2025, debt investments targeted total annualized returns of 10% to 20%.

Show full overview

The 87.1% portfolio concentration across five technology and life sciences sectors creates correlated default risk the 10-K explicitly identifies: a downturn in any heavily concentrated sector could materially affect Hercules more than a diversified portfolio would. The Drug Discovery & Development sector at 23.3% of fair value is subject to binary FDA approval outcomes, patent expiration, and third-party payer reimbursement changes. The Application Software sector at 24.3% faces subscription renewal volatility and AI-driven competitive disruption the 10-K names specifically. Compounding this, Hercules is classified as non-diversified under the 1940 Act, meaning no regulatory minimum diversification requirement constrains single-issuer exposure beyond its RIC tax requirements.

See also: Financial Services · Asset Management

From Hercules Capital, Inc.'s most recent 10-K filing, extracted June 10, 2026.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Jul 30, 202644d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Margin of safety: 42%
Risks
Thin upside margin: 7.6%
Leverage penalty (D/E 1.1): -0.5
Below 200-MA, MA slope -1.7%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)8.7
P/E (Fwd)7.8
Mkt Cap$2.9B
EV/EBITDA11.6
Profit Mgn59.9%
ROE15.7%
Rev Growth18.4%
Beta0.74
Dividend12.14%
Rating analysts15

Quality Signals

Piotroski F4/9MoatNarrow

Options Flow

P/C8.41bearish
IV46%normal
Max Pain$18+15.0% vs spot

Concentration Risks(10-K Item 1A)

  • LOWloan_portfolioApplication Software industry24%
    10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio comprised investments in five industries: 24.3% comprised investments in the "Application Software" industry'
  • LOWloan_portfolioDrug Discovery & Development industry23%
    10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 23.3% comprised investments in the "Drug Discovery & Development" industry'
  • LOWloan_portfolioHealthcare Services, Other industry19%
    10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 18.8% comprised investments in the "Healthcare Services, Other" industry'
  • LOWloan_portfolioSystem Software industry11%
    10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 10.6% in the "System Software" industry'
  • LOWloan_portfolioConsumer & Business Services industry10%
    10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 10.1% comprised investments in the "Consumer & Business Services" industry'

Material Events(8-K, last 90d)

  • 2026-05-04Item 5.02MEDIUM
    CFO Seth H. Meyer (CFO since March 2019) transitions to President effective May 18, 2026, continuing to report to CEO Scott Bluestein. Andrew Olson, age 43, named to leadership team effective May 18, 2026 (successor CFO role implied; body truncated).
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
1.9
Support Resistance
2.5
52w Position
7.4
GatesMomentum 4.5<4.5Death cross (50MA < 200MA)Executive change: officer departure/appointmentA.R:R 1.5 ≥ 1.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 44d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
53 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $15.07Resistance $15.84

Price Targets

$15
$17
A.Upside+7.6%
A.R:R1.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! momentum at 4.5 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-30 (44d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is HTGC stock a buy right now?

Hold if already holding. Not a fresh buy at $15.65, but acceptable to hold if already in. Reasons: Thin upside margin: 7.6%; Leverage penalty (D/E 1.1): -0.5. Chart setup: Death cross but MACD improving, RSI 53. Mixed signals. Hold existing position. Target $16.84 (+7.6%), stop $15.07 (−3.8%), A.R:R 1.5:1. Score 6.0/10, moderate confidence.

What is the HTGC stock price target?

Take-profit target: $16.84 (+7.6% upside). Target $16.84 (+7.6%), stop $15.07 (−3.8%), A.R:R 1.5:1. Stop-loss: $15.07.

What are the risks of investing in HTGC?

Thin upside margin: 7.6%; Leverage penalty (D/E 1.1): -0.5; Below 200-MA, MA slope -1.7%/30d (confirmed downtrend).

Is HTGC overvalued or undervalued?

Hercules Capital, Inc. trades at a P/E of 8.7 (forward 7.8). TrendMatrix value score: 7.7/10. Verdict: Hold.

What do analysts say about HTGC?

15 analysts cover HTGC with a consensus score of 4.1/5. Average price target: $19.

What does Hercules Capital, Inc. do?Hercules Capital is an internally managed BDC regulated under the Investment Company Act of 1940 that provides senior...

Hercules Capital is an internally managed BDC regulated under the Investment Company Act of 1940 that provides senior secured loans and Structured Debt to venture capital-backed and institutional-backed companies in technology and life sciences sectors. The company has originated over $25.0 billion in commitments since inception through December 31, 2025, earning investment income from floating-rate loans (97.9% of portfolio) priced at approximately 7% to 14%.

Related stocks: ETG (Eaton Vance Tax-Advantaged Glob) · SII (Sprott Inc.) · OTF (Blue Owl Technology Finance Cor) · AOD (Aberdeen Total Dynamic Dividend) · RVT (Royce Value Trust, Inc.)
Home Stocks HTGC

Latest news

Latest News

PR Newswire49d agoLegal
Newser28d ago
FinancialContent35d ago
StockStory42d agoEarnings
MarketBeat42d ago
TradingView42d ago
MarketBeat50d agoEarnings
Yahoo Finance22d ago
Thelegaladvocate.com22d ago
Business Wire29d agoLegal
FinancialContent29d agoLegal
PR Newswire29d agoLegal
GlobeNewswire36d agoLegal
StockStory36d agoEarnings
MarketBeat42d ago
MarketBeat42d ago
TipRanks42d ago
Insider Monkey43d ago
FinancialContent48d ago
TMX Newsfile33d agoLegal
Loading more...